DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Galera Therapeutics Q4 EPS $(1.31) Misses $(0.55) Estimate

Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.55) by 138.18 percent.

Benzinga · 03/10/2020 11:04

Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.55) by 138.18 percent.